COPE
Volume 5, Issue 2 (May 2017)                   Res Mol Med (RMM) 2017, 5(2): 1-2 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Talebi Bezmin Abadi A. Viable but Non-culturable Bacteria: Clinical Practice and Future Perspective. Res Mol Med (RMM). 2017; 5 (2) :1-2
URL: http://rmm.mazums.ac.ir/article-1-244-en.html
Abstract:   (1181 Views)
In this editorial, the importance of VBNC in clinical practice and future researches interests has been pinpointed. Accurate detection of VBNC, especially for major mentioned pathogens, is the future research gap. 
Full-Text [PDF 120 kb]   (409 Downloads)    
Type of Study: Research | Subject: Infectious Diseases
Received: 2017/08/27 | Accepted: 2017/11/7 | Published: 2017/11/7

References
1. Kell DB, Kaprelyants AS, Weichart DH, Harwood CR, Barer MR. Viability and activity in readily culturable bacteria: a review and discussion of the practical issues. Antonie van Leeuwenhoek. 1998; 73(2):169-87. PMID: 9717575 [DOI:10.1023/A:1000664013047]
2. Hayes CS, Low DA. Signals of growth regulation in bacteria. Curr Opin Microbiol. 2009; 12(6):667-73. PMID: 19854099 [DOI:10.1016/j.mib.2009.09.006]
3. Figdor D, Davies J, Sundqvist G. Starvation survival, growth and recovery of Enterococcus faecalis in human serum. Oral Microbiol Immunol. 2003; 18(4):234-9. PMID: 12823799 [DOI:10.1034/j.1399-302X.2003.00072.x]
4. Tholozan J, Cappelier J, Tissier J, Delattre G, Federighi M. Physiological Characterization of Viable-but-Nonculturable Campylobacter jejuniCells. Appl Environ Microbiol. 1999; 65(3):1110-6. PMID: 10049870
5. Rahman I, Shahamat M, Chowdhury M, Colwell R. Potential virulence of viable but nonculturable Shigella dysenteriae type 1. Appl Environ Microbiol. 1996; 62(1):115-20. PMID: 8572688
6. Ramamurthy T, Ghosh A, Pazhani GP, Shinoda S. Current perspectives on viable but non-culturable (VBNC) pathogenic bacteria. Front Public Health. 2014; 2:103. PMID: 25133139 [DOI:10.3389/fpubh.2014.00103]
7. Tan SY-E, Chew SC, Tan SY-Y, Givskov M, Yang L. Emerging frontiers in detection and control of bacterial biofilms. Curr Opin Biotechnol. 2014; 26:1-6. PMID: 24679251 [DOI:10.1016/j.copbio.2013.08.002]
8. Abadi ATB. Strategies used by helicobacter pylori to establish persistent infection. World J Gastroenterol. 2017; 23(16):2870. PMID: 28522905 [DOI:10.3748/wjg.v23.i16.2870]
9. Blaser MJ. Ecology of Helicobacter pylori in the human stomach. J Clin Invest. 1997; 100(4):759. PMID: 9259572 [DOI:10.1172/JCI119588]
10. Bode G, Mauch F, Malfertheiner P. The coccoid forms of Helicobacter pylori. Criteria for their viability. Epidemiology and Infection. 2009; 111(3):483-90. PMID: 8270008 [DOI:10.1017/S0950268800057216]
11. Abadi AT, Kusters JG. Management of Helicobacter pylori infections. BMC Gastroenterol. 2016; 16(1):94. PMID: 27520775 [DOI:10.1186/s12876-016-0496-2]
12. Talebi Bezmin Abadi A. Time to Stop Helicobacter pylori, no Matter with Antibiotic, Probiotic or Vaccine. Res Mol Med. 2016; 4(3):1-2. [DOI:10.18869/acadpub.rmm.4.3.1]
13. Leclerc H, Schwartzbrod L, Dei-Cas E. Microbial agents associated with waterborne diseases. Crit Rev Microbiol. 2002; 28(4):371-409. PMID: 12546197 [DOI:10.1080/1040-840291046768]
14. Fakruddin M, Mannan KSB, Andrews S. Viable but nonculturable bacteria: food safety and public health perspective. ISRN microbiology. 2013; 2013.

Add your comments about this article : Your username or Email:
CAPTCHA code

Send email to the article author


© 2018 All Rights Reserved | Research in Molecular Medicine

Designed & Developed by : Yektaweb